A lawsuit was decided last week that, on its face, may seem unimportant, but likely will have major ripple effects on providers participating in the Meaningful Use program. A patient of Ohio-based...
Incurring individual security breaches of electronic patient health information does not necessarily mean that a provider's attestation of meeting Meaningful Use and receiving incentive payments is in violation of the False Claims Act.
Several healthcare provider groups submitted amicus briefs to the Supreme Court urging the reversal of a False Claims Act decision hinging on what they say is an overbroad interpretation of "implied certification."
One of the largest cancer care providers in the country agreed to pay nearly $20 million to resolve claims that it incentivized physicians to order unnecessary urine screening tests used to detect bladder cancer, according to the Department of Justice..
The Department of Justice has secured $28 million in False Claims Act settlements from 32 hospitals for improperly billing a minimially invasive spinal procedure, adding to a long history of previous settlements with more than 100 hospitals and a manufacturer.
Pharmaceutical executives have a long history of avoiding individual charges, even when the company they work for settles for billions to wipe away kickback claims. But the arrest of a pharmaceutical exec last week is one indication that the Yates memo released in September is more than just an empty threat from the feds.
Nearly 500 hospitals in 43 states agreed to pay $250 million in settlements involving cardiac devices that were implanted in patients in violation of Medicare coverage requirements, according to the Department of Justice.
When Tuomey Healthcare System was hit with a $237.5 million judgment in 2013, the South Carolina provider said it would be forced to close its doors. Two years later, the feds are settling for less than one-third of that original judgment following a long, tumultuous legal battle.
The national nursing home pharmacy PharMerica Corp. agreed to pay $9.25 million to resolve claims that it took kickbacks from Abbott Laboratories to promote the anti-seizure medication Depokate, according to the Department of Justice.
A whistleblower lawsuit filed in 2009 against Carolinas Medical Center (CMC) in Charlotte, North Carolina, and N.C. Baptist Hospital in Winston-Salem, claims the providers raked in tens of millions in unsubstantiated Medicare funding by falsely reporting their benefit expenses.